We are live on ! Find out more
JANX icon

Janux Therapeutics
JANX

45 hedge funds and large institutions have $571M invested in Janux Therapeutics in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 9

50% more funds holding

Funds holding: 30 → 45 (+15)

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

1.67% more ownership

Funds ownership: 62.01% → 63.68% (+1.7%)

7% less capital invested

Capital invested by funds: $614M → $571M (-$43.3M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
45
Holders Change
+15
Holders Change %
+50%
% of All Funds
0.79%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
24
Increased
9
Reduced
8
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$51M
2
BlackRock
BlackRock
New York
+$19.9M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$14.4M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.46M
5
State Street
State Street
Massachusetts
+$5.02M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$17.5M
2
LGM
Logos Global Management
California
-$8.63M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$7.24M
4
SB
Samsara BioCapital
California
-$5.64M
5
BI
BVF Inc
California
-$4.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
26
RhumbLine Advisers
Massachusetts
$240K +$320K +11,110 New
CPIG
27
Chicago Partners Investment Group
Illinois
$235K +$272K +9,458 New
Deutsche Bank
28
Deutsche Bank
Germany
$178K +$235K +8,185 New
AIG
29
American International Group
New York
$157K +$208K +7,242 New
California State Teachers Retirement System (CalSTRS)
30
California State Teachers Retirement System (CalSTRS)
California
$155K +$206K +7,149 New
Morgan Stanley
31
Morgan Stanley
New York
$145K +$190K +6,602 +6,602%
JP Morgan Chase
32
JP Morgan Chase
New York
$140K +$168K +5,828 +902%
MIM
33
MetLife Investment Management
New Jersey
$115K +$153K +5,302 New
MLICM
34
Metropolitan Life Insurance Company (MetLife)
New York
$86.8K +$115K +4,011 New
UBS Group
35
UBS Group
Switzerland
$76K +$90.5K +3,147 +892%
SO
36
STRS Ohio
Ohio
$64K +$86.3K +3,000 New
Bank of America
37
Bank of America
North Carolina
$63K +$25.8K +895 +44%
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$61K +$44.2K +1,537 +118%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$50K +$66.2K +2,300 New
Citigroup
40
Citigroup
New York
$38K -$2.44M -84,940 -98%
Legal & General Group
41
Legal & General Group
United Kingdom
$27K +$35.6K +1,239 New
AIP
42
Ameritas Investment Partners
Nebraska
$22K +$29.2K +1,014 New
TRCT
43
Tower Research Capital (TRC)
New York
$11K +$15K +522 New
EWA
44
Evolution Wealth Advisors
Florida
$3K +$3.57K +124 New
Wells Fargo
45
Wells Fargo
California
$2K +$2.13K +74 New
DM
46
Deerfield Management
New York
– -$17.5M -700,000 Closed
Millennium Management
47
Millennium Management
New York
– -$1.88M -75,257 Closed
Goldman Sachs
48
Goldman Sachs
New York
– -$1.72M -69,000 Closed
LP
49
LMR Partners
United Kingdom
– -$1.42M -57,000 Closed
PCM
50
Pinz Capital Management
New York
– -$801K -32,100 Closed
1
2
3

JANX Hedge Fund Activity: Q3 2021 in Review

45 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Janux Therapeutics (JANX) for Q3 2021, worth a combined $571M — down 7% from $614M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new JANX positions and 9 closed out — a net gain of 15 holders — while 9 added to existing stakes and 8 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $51M. The largest seller was Deerfield Management, exiting entirely with an estimated $17.5M sold.

  • 45 institutional investors held Janux Therapeutics (JANX) as of Q3 2021, up from 30 in Q2 2021.
  • Funds reported $571M of Janux Therapeutics stock for Q3 2021, down 7% quarter-over-quarter.
  • 24 funds opened new Janux Therapeutics positions in Q3 2021 and 9 closed out, a net change of +15 holders.
  • The largest Janux Therapeutics buyer in Q3 2021 was Fidelity Investments, an estimated $51M added.
  • The largest Janux Therapeutics seller in Q3 2021 was Deerfield Management, an estimated $17.5M sold.

Based on aggregated 13F filings for Q3 2021.